Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Oman.
Campus
Campus

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Learn more
VTE prophylaxis in medically ill patients

VTE prophylaxis in medically ill patients

Learn more
Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Learn more
Odyssey Outcomes - PVD Sub-analysis

Odyssey Outcomes - PVD Sub-analysis

Learn more
Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Learn more
Odyssey Outcomes - Total Events Analysis

Odyssey Outcomes - Total Events Analysis

Learn more
Odyssey outcomes - CVOT mortality sub-analysis

Odyssey outcomes - CVOT mortality sub-analysis

Learn more
LLTs Exposure Time and Major Vascular Risk Reduction

LLTs Exposure Time and Major Vascular Risk Reduction

Learn more
Improving Lipid Management for Patients Post-ACS

Improving Lipid Management for Patients Post-ACS

Learn more
Dyslipidemia performance of 2016 2019 and 2021 ESC Dyslipidemia guidelines

Dyslipidemia performance of 2016 2019 and 2021 ESC Dyslipidemia guidelines

Learn more
The role of the patient in Achieving LDL-C Target

The role of the patient in Achieving LDL-C Target

Learn more
Identifying and treating patients with high Lipidaemia risk post-ACS

Identifying and treating patients with high Lipidaemia risk post-ACS

Learn more